Europe PMC
open access
CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease#877463
- Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease#896481
- A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder.#323217
- Psilocybin in Alcohol Use Disorder With Comorbid Depression#1059843
- Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder#993267
Record · ID 676456
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive